Clinical trials
Recruiting Hypercholesterolemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2023 | 1 |
| 2024 | 7 |
| 2025 | 6 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| AstraZeneca | 2 |
| Baylor Research Institute | 1 |
| Brigham and Women's Hospital | 1 |
| CRISPR Therapeutics AG | 1 |
| Cambridge Health Alliance | 1 |
| Duke University | 1 |
| Midwest Center for Metabolic and Cardiovascular Research | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| Sairam Parthasarathy | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 22 |
| Hyperlipidemias | 8 |
| Cardiovascular Diseases | 4 |
| Hyperlipoproteinemia Type II | 4 |
| Lipid Metabolism Disorders | 4 |
| Atherosclerosis | 3 |
| Diabetes Mellitus | 3 |
| Dyslipidemias | 3 |
| Heart Failure | 3 |
| Homozygous Familial Hypercholesterolemia | 3 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.